Visual exploration in Parkinson's disease and Parkinson's disease dementia

Brain

Volumn 136, Issue 3, 2013, Pages 739-750

  Archibald, Neil K ^a   Hutton, Sam B ^b   Clarke, Michael P ^c   Mosimann, Urs P ^c,d   Burn, David J ^c  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

fixation; Parkinson's disease; Parkinson's disease dementia; saccade; visual exploration

Indexed keywords

ANTIPARKINSON AGENT;

AGED; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; EXPLORATORY BEHAVIOR; EYE FIXATION; EYE TRACKING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MODEL; PARKINSON DISEASE; PREDICTIVE VALUE; PRIORITY JOURNAL; SACCADIC EYE MOVEMENT; STIMULUS RESPONSE; TASK PERFORMANCE; VISION; VISUAL STIMULATION;

EID: 84874856945     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt005     Document Type: Article

References (74)

1. Amick MM, Schendan HE, Ganis G, Cronin-Golomb A. Frontostriatal circuits are necessary for visuomotor transformation: mental rotation in Parkinson's disease. Neuropsychologia 2006; 44: 339-49.
2. Anastasopoulos D, Ziavra N, Savvidou E, Bain P, Bronstein AM. Altered eye-to-foot coordination in standing parkinsonian patients during large gaze and whole-body reorientations. Mov Disord 2011; 26: 2201-11.
3. Bares M, Brazdil M, Kanovsky P, Jurá k P, Daniel P, Kukleta M, et al. The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients. Parkinsonism Relat Disord 2003; 9: 139-44.
4. Barker RA, Michell AW. "The eyes have it". Saccadometry and Parkinson's disease. Exp Neurol 2009; 219: 382-4.
5. Beyer MK, Larsen JP, Aarsland D. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 2007; 69: 747-54.
6. Briand KA, Hening W, Poizner H, Sereno AB. Automatic orienting of visuospatial attention in Parkinson's disease. Neuropsychologia 2001; 39: 1240-9.
7. Briand KA, Strallow D, Hening W, Poizner H, Sereno AB. Control of voluntary and reflexive saccades in Parkinson's disease. Exp Brain Res 1999; 129: 38-48.
8. Brown GG, Rahill AA, Gorell JM, McDonald C, Brown SJ, Sillanpaa M, et al. Validity of the Dementia Rating Scale in assessing cognitive function in Parkinson's disease. J Geriatr Psychiatry Neurol 1999; 12: 180-8.
9. Cahn-Weiner DA, Williams K, Grace J, Tremont G, Westervelt H, Stern RA. Discrimination of dementia with lewy bodies from Alzheimer disease and Parkinson disease using the clock drawing test. Cogn Behav Neurol 2003; 16: 85-92.
10. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007; 22: 1272-7.
11. Chambers JM, Prescott TJ. Response times for visually guided saccades in persons with Parkinson's disease: a meta-analytic review. Neuropsychologia 2010; 48: 887-99.
12. Clark US, Neargarder S, Cronin-Golomb A. Visual exploration of emotional facial expressions in Parkinson's disease. Neuropsychologia 2010; 48: 1901-13.
13. Corin MS, Elizan TS, Bender MB. Oculomotor function in patients with Parkinson's disease. J Neurol Sci 1972; 15: 251-65.
14. Cormack F, Aarsland D, Ballard C, Tovee MJ. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry 2004; 19: 371-7.
15. De Renzi E, Scotti G, Spinnler H. Perceptual and associative disorders of visual recognition. Relationship to the side of the cerebral lesion. Neurology 1969; 19: 634-42.
16. Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 2007; 22: 1689-707; quiz 1837.
17. Fahn S, Elton RL. Members of the Unified Parkinson's Disease Rating Scale Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, editors. Recent developments in Parkinson's disease. New York: Macmillan; 1987. p. 153-63.
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
19. Foltynie T, Brayne CEG, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004; 127: 550-60.
20. Galna B, Lord S, Daud D, Archibald N, Burn D, Rochester L. Visual sampling during walking in people with Parkinson's disease and the influence of environment and dual-task. Brain Res 2012; 1473: 35-43.
21. Ghent L. Perception of overlapping and embedded figures by children of different ages. Am J Psychol 1956; 69: 575-87.
22. Goodale MA, Milner AD. Separate visual pathways for perception and action. Trends Neurosci 1992; 15: 20-25.
23. Gottlob I, Proudlock FA, Shekhar H, Rajabally Y. Reading in Parkinson's disease. Invest Ophthalmol Visual Sci 2004; 45: 2517.
24. Greany JF, Di Fabio RP. Saccade to stepping delays in elders at high risk for falling. Aging Clin Exp Res 2008; 20: 428-33.
25. Henderson JM, Hollingworth A. High-level scene perception. Annu Rev Psychol 1999; 50: 243-71.
26. Hikosaka O, Takikawa Y, Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 2000; 80: 953-78.
27. Hodgson TL, Dittrich WH, Henderson L, Kennard C. Eye movements and spatial working memory in Parkinson's disease. Neuropsychologia 1999; 37: 927-38.
28. Hodgson TL, Tiesman B, Owen AM, Kennard C. Abnormal gaze strategies during problem solving in Parkinson's disease. Neuropsychologia 2002; 40: 411-22.
29. Hollands MA, Ziavra NV, Bronstein AM. A new paradigm to investigate the roles of head and eye movements in the coordination of whole-body movements. Exp Brain Res 2004; 154: 261-6.
30. Hood AJ, Amador SC, Cain AE, Briand KA, Al-Refai AH, Schiess MC, et al. Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 565-70.
31. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4.
32. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 2006; 21: 1343-9.
33. Kennard C, Lueck CJ. Oculomotor abnormalities in diseases of the basal ganglia. Rev Neurol (Paris) 1989; 145: 587-95.
34. Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, et al. MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord 2011; 26: 1814-24.
35. Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 2012; 27: 349-56.
36. Lo RY, Tanner CM, Albers KB, Leimpeter AD, Fross RD, Bernstein AL, et al. Clinical features in early Parkinson disease and survival. Arch Neurol 2009; 66: 1353-8.
37. Lohnes C, Earhart G. Saccadic eye movements are related to turning performance in Parkinson disease. J Parkinsons Dis 2011; 1: 109-18.
38. Lueck CJ, Tanyeri S, Crawford TJ, Henderson L, Kennard C. Antisaccades and remembered saccades in Parkinson's disease. J Neurol Neurosurg Psychiatry 1990; 53: 284-8.
39. Lueck KL, Mendez MF, Perryman KM. Eye movement abnormalities during reading in patients with Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol 2000; 13: 77-82.
40. MacAskill MR, Anderson TJ, Jones RD. Adaptive modification of saccade amplitude in Parkinson's disease. Brain 2002; 125: 1570-82.
41. MacQuarrie TW. MacQuarrie's test for mechanical ability. Monterey, CA: California Test Bureau; 1953.
42. Matsumoto H, Terao Y, Furubayashi T, Yugeta A, Fukuda H, Emoto M, et al. Small saccades restrict visual scanning area in Parkinson's disease. Mov Disord 2011; 26: 1619-26.
43. Michell AW, Xu Z, Fritz D, Lewis SJ, Foltynie T, Williams-Gray CH, et al. Saccadic latency distributions in Parkinson's disease and the effects of L-dopa. Exp Brain Res 2006; 174: 7-18.
44. Montse A, Pere V, Carme J, Francesc V, Eduardo T. Visuospatial deficits in Parkinson's disease assessed by judgment of line orientation test: error analyses and practice effects. J Clin Exp Neuropsychol 2001; 23: 592-8.
45. Mori E, Shimomura T, Fujimori M, Hirono N, Imamura T, Hashimoto M, et al. Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 2000; 57: 489-93.
46. Mosimann UP, Felblinger J, Ballinari P, Hess CW, Muri RM. Visual exploration behaviour during clock reading in Alzheimer's disease. Brain 2004a; 127: 431-8.
47. Mosimann UP, Mather G, Wesnes KA, O'Brien JT, Burn DJ, McKeith IG. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 2004b; 63: 2091-6.
48. Mosimann UP, Muri RM, Burn DJ, Felblinger J, O'Brien JT, McKeith IG. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Brain 2005; 128: 1267-76.
49. Muri RM, Vermersch AI, Rivaud S, Gaymard B, Pierrot-Deseilligny C. Effects of single-pulse transcranial magnetic stimulation over the prefrontal and posterior parietal cortices during memory-guided saccades in humans. J Neurophysiol 1996; 76: 2102-6.
50. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005; 65: 1239-45.
51. Newman EJ, Breen K, Patterson J, Hadley DM, Grosset KA, Grosset DG. Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland. Mov Disord 2009; 24: 2379-85.
52. Ogrocki PK, Hills AC, Strauss ME. Visual exploration of facial emotion by healthy older adults and patients with Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol 2000; 13: 271-8.
53. Pereira JB, Junque C, Marti M-J, Ramirez-Ruiz B, Bargallo N, Tolosa E. Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease. Mov Disord 2009; 24: 1193-9.
54. Perneczky R, Ghosh BC, Hughes L, Carpenter RH, Barker RA, Rowe JB. Saccadic latency in Parkinson's disease correlates with executive function and brain atrophy, but not motor severity. Neurobiol Dis 2011; 43: 79-85.
55. Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, et al. Mild cognitive impairment: ten years later. Arch Neurol 2009; 66: 1447-55.
56. Pierrot-Deseilligny C, Muri R, Nyffeler T, Milea D. The role of the human dorsolateral prefrontal cortex in ocular motor behavior. Ann N Y Acad Sci 2005; 1039: 239-51.
57. Pierrot-Deseilligny C, Rivaud S, Gaymard B, Agid Y. Cortical control of memory-guided saccades in man. Exp Brain Res 1991; 83: 607-17.
58. Pierrot-Deseilligny C, Rivaud S, Gaymard B, Muri R, Vermersch AI. Cortical control of saccades. Ann Neurol 1995; 37: 557-67.
59. Poppelreuter W. Die psychischen Scha? digungen durch Kopfschuss im Kriege 1914-1916: die Herabsetzung der ko? rperlichen Leistungsfa? higkeit und des Arbeitswillens durch Hirnverletzung im Vergleich zu Normalen und Psychogenen. Leipzig: Voss; 1917.
60. Rascol O, Clanet M, Montastruc JL, Simonetta M, Soulier-Esteve MJ, Doyon B, et al. Abnormal ocular movements in Parkinson's disease. evidence for involvement of dopaminergic systems. Brain 1989; 112: 1193-4.
61. Repka MX, Claro MC, Loupe DN, Reich SG. Ocular motility in Parkinson's disease. J Pediatr Ophthalmol Strabismus 1996; 33: 144-7.
62. Schmidtke K, Olbrich S. The Clock Reading Test: validation of an instrument for the diagnosis of dementia and disorders of visuo-spatial cognition. Int Psychogeriatr 2007; 19: 307-21.
63. Shulman KI. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry 2000; 15: 548-61.
64. Spildooren J, Vercruysse S, Desloovere K, Vandenberghe W, Kerckhofs E, Nieuwboer A. Freezing of gait in Parkinson's disease: the impact of dual-tasking and turning. Mov Disord 2010; 25: 2563-70.
65. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649-53.
66. Uc EY, Rizzo M, Anderson SW, Qian S, Rodnitzky RL, Dawson JD. Visual dysfunction in Parkinson disease without dementia. Neurology 2005; 65: 1907-13.
67. Ungerleider LG, Mishkin M. Two cortical visual systems. In: Ingle DG, Goodale MA, Mansfield RJQ, editors. Analysis of visual behaviour. Cambridge: MIT Press; 1982. p. 549-86.
68. van Stockum S, MacAskill M, Anderson T, Dalrymple-Alford J. Don't look now or look away: two sources of saccadic disinhibition in Parkinson's disease? Neuropsychologia 2008; 46: 3108-15.
69. Vidailhet M, Rivaud S, Gouider-Khouja N, Pillon B, Bonnet AM, Gaymard B, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994; 35: 420-6.
70. Vidailhet M, Rivaud S, Gouider-Khouja N, Pillon B, Gaymard B, Agid Y, et al. Saccades and antisaccades in parkinsonian syndromes. Adv Neurol 1999; 80: 377-82.
71. Warrington EK, James M. Visual apperceptive agnosia: a clinicoanatomical study of three cases. Cortex 1988; 24: 13-32.
72. White OB, Saint-Cyr JA, Tomlinson RD, Sharpe JA. Ocular motor deficits in Parkinson's disease. II. Control of the saccadic and smooth pursuit systems. Brain 1983; 106: 571-87.
73. Williams-Gray CH, Foltynie T, Brayne CEG, Robbins TW, Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007; 130: 1787-98.
74. Yarnall A, Rochester L, Burn DJ. The interplay of cholinergic function, attention, and falls in Parkinson's disease. Mov Disord 2011; 26: 2496-503.